RLAY
Relay Therapeutics Inc

1,153
Mkt Cap
$1.83B
Volume
8.21M
52W High
$11.43
52W Low
$1.78
PE Ratio
-5.86
RLAY Fundamentals
Price
$10.26
Prev Close
$9.16
Open
$9.64
50D MA
$8.36
Beta
1.87
Avg. Volume
2.22M
EPS (Annual)
-$1.61
P/B
2.91
Rev/Employee
$79,973.96
$929.56
Loading...
Loading...
News
all
press releases
Wells Fargo & Company Boosts Relay Therapeutics (NASDAQ:RLAY) Price Target to $15.00
Wells Fargo & Company raised their price objective on Relay Therapeutics from $13.00 to $15.00 and gave the stock an "overweight" rating in a research note on Friday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Sets New 52-Week High on Strong Earnings
Relay Therapeutics (NASDAQ:RLAY) Hits New 52-Week High Following Better-Than-Expected Earnings...
MarketBeat·2d ago
News Placeholder
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million
Key PointsCasdin Capital bought 1,662,193 shares of Relay Therapeutics; the estimated trade size was $11.86 million...
Nasdaq News: Markets·2d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Announces Quarterly Earnings Results
Relay Therapeutics (NASDAQ:RLAY - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.32) EPS for the quarter, topping the consensus estimate of ($0.38) by...
MarketBeat·3d ago
News Placeholder
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Relay Therapeutics (RLAY) delivered earnings and revenue surprises of +16.51% and -52.91%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Private Capital Advisors Inc. Cuts Stake in Relay Therapeutics, Inc. $RLAY
Private Capital Advisors Inc. cut its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY - Free Report) by 87.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·3d ago
News Placeholder
Relay Therapeutics Earnings Preview
read more...
Benzinga·4d ago
News Placeholder
Relay Therapeutics (RLAY) to Release Quarterly Earnings on Wednesday
Relay Therapeutics (NASDAQ:RLAY) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of "Moderate Buy" by Analysts
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) have been given an average rating of "Moderate Buy" by the eight ratings firms that are covering the company, MarketBeat.com...
MarketBeat·15d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Sets New 12-Month High - Time to Buy?
Relay Therapeutics (NASDAQ:RLAY) Reaches New 12-Month High - Time to Buy...
MarketBeat·20d ago
<
1
2
...
>

Latest RLAY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.